Education

  • 2025 - Fellow
    UC San Francisco, Cellular Therapy and Transfusion Medicine
  • 2024 - Resident
    UC San Francisco, Clinical Pathology
  • 2019 - PhD
    University of Pennsylvania, Immunology
  • 2022 - MD
    University of Pennsylvania, Medicine
  • 2008 - BA
    UC Berkeley, Molecular and Cellular Biology
     

Honors & Awards

  • 2026
    CRISPR Cures for Cancer Research Award, UCSF, UC Berkeley, and The Gladstone Institutes
  • 2026
    Marcus Program - Transformative Integrated Research Award, UCSF
  • 2024
    Center for Translational Research in Cell Therapy and Transfusion Medicine – Pilot Award, University of California, San Francisco
  • 2024
    CRISPR Cures for Cancer Initiative – Pilot Award, UCSF, UC Berkeley, and The Gladstone Institutes
  • 2023
    Dr. Julius Krevans Award, Zuckerberg San Francisco General Hospital and the Gladstone Institute
  • 2019
    Dr. Roy G. Williams Research Paper Award, University of Pennsylvania
  • 2017
    Penn HealthX Venture Fund Award, University of Pennsylvania
  • 2017
    Innovation Seed Grant Award, Singh Center for Nanotechnology, University of Pennsylvania
  • 2017
    NRSA F30 Fellowship Award, National Institutes of Health, NIAID

Selected Publications

  1. Khan OA. Global Health in an Interconnected World: Opportunities and Challenges. Dela J Public Health. 2025 Apr; 11(1):6-7. View on PubMed
  2. Khan O, Prakash S, Chung A, Wong SW, Kennedy VE. Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy. Am J Med. 2024 07; 137(7):589-591. View on PubMed
  3. Khan OA, Kavanaugh EM, Monteleone RA, Vasagar B, Robert JF. Family Medicine Training in The US and Delaware:: Opportunities and Growth in Primary Care Workforce. Dela J Public Health. 2023 Dec; 9(5):20-23. View on PubMed
  4. Pal SK, Albiges L, Tomczak P, Suárez C, Voss MH, de Velasco G, Chahoud J, Mochalova A, Procopio G, Mahammedi H, Zengerling F, Kim C, Osawa T, Angel M, Gupta S, Khan O, Bergthold G, Liu B, Kalaitzidou M, Huseni M, Scheffold C, Powles T, Choueiri TK. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2023 07 15; 402(10397):185-195. View on PubMed
  5. Khan KR, Khan OA, Chen C, Liu Y, Kandanelly RR, Jamiel PJ, Tanguturi V, Hung J, Inglessis I, Passeri JJ, Langer NB, Elmariah S. Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2023 04 04; 81(13):1235-1244. View on PubMed
  6. Bolckmans R, Askari A, Currie A, Ahmed AR, Batterham RL, Byrne J, Hopkins J, Khan OA, Mahawar K, Miras AD, Pring CM, Small PK, Welbourn R. Clinical characteristics of patients undergoing primary bariatric surgery in the United Kingdom based on the National Bariatric Surgery Registry. Clin Obes. 2023 Jun; 13(3):e12585. View on PubMed
  7. Das B, Ledesma F, Ashrafian H, Reddy M, Khan OA, Fehervari M. Gastrojejunostomy Closure Technique and Risk of Leak: an Evaluation in Ex Vivo Porcine Models. Obes Surg. 2023 03; 33(3):978-981. View on PubMed
  8. Khan OA, Gardner P. Welcome from the Delaware Health Sciences Alliance. Dela J Public Health. 2022 Dec; 8(5):10. View on PubMed
  9. Pal SK, Uzzo R, Karam JA, Master VA, Donskov F, Suarez C, Albiges L, Rini B, Tomita Y, Kann AG, Procopio G, Massari F, Zibelman M, Antonyan I, Huseni M, Basu D, Ci B, Leung W, Khan O, Dubey S, Bex A. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Lancet. 2022 10 01; 400(10358):1103-1116. View on PubMed
  10. Uppal P, Golden BL, Panicker A, Khan OA, Burday MJ. The Case Against Race-Based GFR. Dela J Public Health. 2022 Aug; 8(3):86-89. View on PubMed
  11. Eppes SC, Khan OA. From the Guest Editors. Dela J Public Health. 2022 Mar; 8(1):4-5. View on PubMed
  12. Motzer RJ, Powles T, Atkins MB, Escudier B, McDermott DF, Alekseev BY, Lee JL, Suarez C, Stroyakovskiy D, De Giorgi U, Donskov F, Mellado B, Banchereau R, Hamidi H, Khan O, Craine V, Huseni M, Flinn N, Dubey S, Rini BI. Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. JAMA Oncol. 2022 Feb 01; 8(2):275-280. View on PubMed
  13. Culley MK, Zhao J, Tai YY, Tang Y, Perk D, Negi V, Yu Q, Woodcock CC, Handen A, Speyer G, Kim S, Lai YC, Satoh T, Watson AM, Aaraj YA, Sembrat J, Rojas M, Goncharov D, Goncharova EA, Khan OF, Anderson DG, Dahlman JE, Gurkar AU, Lafyatis R, Fayyaz AU, Redfield MM, Gladwin MT, Rabinovitch M, Gu M, Bertero T, Chan SY. Frataxin deficiency promotes endothelial senescence in pulmonary hypertension. J Clin Invest. 2021 06 01; 131(11). View on PubMed
  14. Currie AC, Kaur V, Carey I, Al-Rubaye H, Mahawar K, Madhok B, Small P, McGlone ER, Khan OA. Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study. Surg Obes Relat Dis. 2021 Sep; 17(9):1576-1582. View on PubMed
  15. McGlone ER, Malallah K, Cuenco J, Wewer Albrechtsen NJ, Holst JJ, Vincent RP, Ling C, Khan OA, Verma S, Ahmed AR, Walters JRF, Khoo B, Bloom SR, Tan TMM. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study. Am J Physiol Endocrinol Metab. 2021 04 01; 320(4):E671-E679. View on PubMed
  16. McGlone ER, Carey I, Velickovic V, Chana P, Mahawar K, Batterham RL, Hopkins J, Walton P, Kinsman R, Byrne J, Somers S, Kerrigan D, Menon V, Borg C, Ahmed A, Sgromo B, Cheruvu C, Bano G, Leonard C, Thom H, le Roux CW, Reddy M, Welbourn R, Small P, Khan OA. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses. PLoS Med. 2020 12; 17(12):e1003228. View on PubMed
  17. Lo C, Khan OA. An Invited Commentary on "Comparative risk of fracture for bariatric procedures in patients with obesity: A systematic review and Bayesian network meta-analysis" (Int J Surg 2020; 75: 13-23) - Metabolic effects of bariatric surgery. Int J Surg. 2020 06; 78:56-57. View on PubMed
  18. Murphy KR, Khan OA, Rassa AC, Elman MR, Chadderdon SM, Song HK, Golwala H, Cigarroa JE, Zahr FE. Clinical and Echocardiographic Predictors of Outcomes in Patients With Moderate (Mean Transvalvular Gradient 20 to 40 mm Hg) Aortic Stenosis. Am J Cardiol. 2019 12 15; 124(12):1924-1931. View on PubMed
  19. Reese T, Dickson AL, Shuey MM, Gandelman JS, Barnado A, Barker KA, Neal JE, Khan OA, Dupont WD, Stein CM, Chung CP. Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burden. Lupus. 2019 Jul; 28(8):954-960. View on PubMed
  20. Yu Q, Tai YY, Tang Y, Zhao J, Negi V, Culley MK, Pilli J, Sun W, Brugger K, Mayr J, Saggar R, Saggar R, Wallace WD, Ross DJ, Waxman AB, Wendell SG, Mullett SJ, Sembrat J, Rojas M, Khan OF, Dahlman JE, Sugahara M, Kagiyama N, Satoh T, Zhang M, Feng N, Gorcsan J, Vargas SO, Haley KJ, Kumar R, Graham BB, Langer R, Anderson DG, Wang B, Shiva S, Bertero T, Chan SY. BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension. Circulation. 2019 05 07; 139(19):2238-2255. View on PubMed

Go to UCSF Profiles, powered by CTSI